Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population-scale chemical response revealed by a barcoded yeast collection.

Nature communications·2026
Same author

A Physics-Informed Neural Network (PINN) Approach to Over-Equilibrium Dynamics in Conservatively Perturbed Linear Equilibrium Systems.

Entropy (Basel, Switzerland)·2026
Same author

Domestication drives repeated evolution of sexual-asexual life cycle trade-offs in yeast.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

An empirical long-term competition among natural yeast isolates reveals that short-term fitness largely but not entirely predicts long-term outcomes.

bioRxiv : the preprint server for biology·2025
Same author

Shaping robust dynamic inversion control of neural cell dynamics.

Biomedical physics & engineering express·2025
Same author

Developing a Zn(II)-metallovesicle for loading and delivering doxorubicin to kill cancer cells-a multi-drug delivery system.

Chemical communications (Cambridge, England)·2025

Related Experiment Video

Updated: Jul 9, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K

Reparameterized multiobjective control of BCG immunotherapy.

Rongting Yue1, Abhishek Dutta2

  • 1Electrical and Computer Engineering, University of Connecticut, Storrs, 06269, USA. rongting.yue@uconn.edu.

Scientific Reports
|November 27, 2023
PubMed
Summary
This summary is machine-generated.

Optimizing Bacillus of Calmette and Guerin (BCG) immunotherapy drug dosing through a novel reparameterized multiobjective control approach effectively eliminates bladder cancer cells. This method offers a potential framework for advanced, model-based cancer treatment designs.

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K

Related Experiment Videos

Last Updated: Jul 9, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K

Area of Science:

  • Oncology
  • Immunotherapy
  • Control Theory

Background:

  • Bladder cancer significantly impacts elder populations.
  • Bacillus of Calmette and Guerin (BCG) immunotherapy is effective but requires optimal drug dosing.
  • Designing optimal BCG regimens remains a challenge in bladder cancer treatment.

Purpose of the Study:

  • To propose and apply the reparameterized multiobjective control (RMC) approach for optimizing BCG drug dosing regimens.
  • To compare the RMC approach with Koopman model predictive control (MPC).
  • To validate the efficacy of optimized BCG dosing for bladder cancer treatment.

Main Methods:

  • Utilized a nonlinear bladder cancer model with impulsive drug instillation.
  • Applied constrained optimization within the RMC framework.
  • Conducted numerical simulations to compare RMC with Koopman MPC.

Main Results:

  • The RMC approach successfully identified optimal BCG dosing regimens.
  • Numerical simulations demonstrated efficient elimination of cancerous cells using the proposed optimal regimens.
  • The RMC approach showed comparable or superior performance to Koopman MPC.

Conclusions:

  • The reparameterized multiobjective control (RMC) approach is effective for designing optimal BCG dosing regimens in bladder cancer.
  • Optimized BCG dosing regimens can lead to efficient eradication of cancerous cells.
  • The proposed control framework has potential for broader application in model-based cancer therapy design.